David Pastorino, Phd

Mimetis Biomaterials designs, manufactures and commercializes bone regenerative solutions in the dental and orthopaedic fields. Mimetis uses biomimicry as a differential technological basis, synthetically manufacturing a bone graft that closely mimics the natural bone of the patient in order to regenerate it physiologically. The results are safe, with optimal performance and clinical reliability. The biomimetic portfolio of the company includes 3D-printed bone for patient-specific indications to provide solutions for complex cases.

Mimetis Biomaterials designs, manufactures and commercializes bone regenerative solutions in the dental and orthopaedic fields. Mimetis uses biomimicry as a differential technological basis, synthetically manufacturing a bone graft that closely mimics the natural bone of the patient in order to regenerate it physiologically. The results are safe, with optimal performance and clinical reliability. The biomimetic portfolio of the company includes 3D-printed bone for patient-specific indications to provide solutions for complex cases.

Mimetis Biomaterials designs, manufactures and commercializes bone regenerative solutions in the dental and orthopaedic fields. Mimetis uses biomimicry as a differential technological basis, synthetically manufacturing a bone graft that closely mimics the natural bone of the patient in order to regenerate it physiologically. The results are safe, with optimal performance and clinical reliability. The biomimetic portfolio of the company includes 3D-printed bone for patient-specific indications to provide solutions for complex cases.

ZAGA is a method that can guarantee the long-term success of treating cases of maxillary atrophy with zygomatic implants. The method drastically improves upon the results of other techniques and above all, its approach focuses on applying the advances in medicine to improve patient well-being. Zygoma Integrated Solutions is an organizational platform consisting of patients, professionals, protocols, experiences, research and scientific developments that are related to the ZAGA method. Its objective is to safely extend the use of zygomatic implants by coordinating the relationships between patients, dentists (ZAGA Partners) and professionals who are highly-trained in the field of zygomatic implants (ZAGA Centers).

Mimetis Biomaterials designs, manufactures and commercializes bone regenerative solutions in the dental and orthopaedic fields. Mimetis uses biomimicry as a differential technological basis, synthetically manufacturing a bone graft that closely mimics the natural bone of the patient in order to regenerate it physiologically. The results are safe, with optimal performance and clinical reliability. The biomimetic portfolio of the company includes 3D-printed bone for patient-specific indications to provide solutions for complex cases.